Description
Seeking men and women with cutaneous lupus erythematosus (CLE), a form of lupus that affects the skin, for a study of an study of an investigational drug.
Overview
Participants in this study will either get the investigational drug or a placebo (looks like the investigational drug but contains no medicine) for the first 24 weeks. For the next 24 weeks all participants will get the investigational drug. Participants will continue to take all their current standard treatments for cutaneous lupus erythematosus (CLE) throughout the study.
What we're hoping for
We are studying whether adding an investigational drug to standard treatment is safe and effective in controlling symptoms of cutaneous lupus erythematosus (CLE) on the skin.
Additional Information
ClinicalTrials.gov Identifier: NCT05531565